Healthcare -
Biotechnology - NASDAQ - US
$ 59.76
1.03 %
$ 7.36 B
Market Cap
17.42
P/E
HALO - TOTAL RECEIVABLES
Total Receivables HALO - Halozyme Therapeutics, Inc.
308 M
LAST VALUE
15.54%
2 YEAR CAGR
39.00%
5 YEAR CAGR
42.16%
10 YEAR CAGR